161 related articles for article (PubMed ID: 5322537)
1. Examinations of the bactericidal properties of the serum against gram-positive microbes in patients suffering from leukaemia, malignant lymphoma, myeloma and myelofibrosis.
Libánský J; Jezková Z
Experientia; 1964 Mar; 20(3):124-7. PubMed ID: 5322537
[No Abstract] [Full Text] [Related]
2. [Significance of the HL-A-antigensystem in tumor research].
Kuwert E; Bertrams J
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972; 78(2):204-18. PubMed ID: 4264844
[No Abstract] [Full Text] [Related]
3. The investigation of the immunological reactivity of patients with haemoblastosis.
Libánský J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1965; 84(2):172-89. PubMed ID: 4161254
[No Abstract] [Full Text] [Related]
4. [Immunoglobulin composition of the blood in hemolymphoblastosis].
Medina F; Tognella S
Folia Allergol (Roma); 1967; 14(6):447-52. PubMed ID: 4171226
[No Abstract] [Full Text] [Related]
5. Immunologic studies in lymphoma and leukemia, and exploration of antitumor immunotherapy.
Sokal JE
J Surg Oncol; 1973 Jun; 5(6):557-66. PubMed ID: 4589652
[No Abstract] [Full Text] [Related]
6. Immune responsiveness and hematologic malignancy in the elderly.
Fernandez G; Schwartz JM
Med Clin North Am; 1976; 60(6):1253-71. PubMed ID: 790049
[No Abstract] [Full Text] [Related]
7. STUDY OF IMMUNOLOGIC REACTIVITY IN HEMOBLASTOSIS. CIRCULATING ANTIBODY FORMATION AS A RESPONSE TO ANTIGENIC STIMULUS IN LEUKEMIA, MALIGNANT LYMPHOMA, MYELOMA AND MYELOFIBROSIS.
LIBANSKY J
Blood; 1965 Feb; 25():169-78. PubMed ID: 14267693
[No Abstract] [Full Text] [Related]
8. Immune deficiency states associated with malignant disease in man.
Harris J; Bagai RC
Med Clin North Am; 1972 Mar; 56(2):501-14. PubMed ID: 4623010
[No Abstract] [Full Text] [Related]
9. Presence of chronic lymphoid leukaemia associated antigen in other malignant haematological diseases.
Phan DT; Petrányi GG; Hollán SR
Vox Sang; 1974 Feb; 26(2):141-6. PubMed ID: 4207851
[No Abstract] [Full Text] [Related]
10. [Blastic lymphocyte transformation caused by phytohemagglutinin in patients with lymphoproliferative diseases].
Mantovani G; Petrini MT; Tognella S; Grifoni V
Boll Soc Ital Biol Sper; 1972 Jul; 48(14):381-5. PubMed ID: 4628299
[No Abstract] [Full Text] [Related]
11. [Immunologic deficiencies in malignant diseases of the lymphoma group and in multiple myeloma].
Hartl W; Hayduk K
Arch Klin Med; 1967 Nov; 214(1):54-69. PubMed ID: 4872039
[No Abstract] [Full Text] [Related]
12. EBV infections in Brazil. I. Occurrence in normal persons, in lymphomas and in leukemias.
Carvalho RP; Evans AS; Frost P; Dalldorf G; Camargo ME; Jamra M
Int J Cancer; 1973 Jan; 11(1):191-201. PubMed ID: 4364322
[No Abstract] [Full Text] [Related]
13. [Current trends in therapy and prophylaxis of immunological disorders in malignant hemoreticulopathies].
Berceanu S; Gociu M
Stud Cercet Med Interna; 1969; 10(3):197-208. PubMed ID: 4186583
[No Abstract] [Full Text] [Related]
14. INVESTIGATIONS OF THE IMMUNOLOGICAL REACTIVITY IN HAEMOBLASTOSES. IV. THE BACTERICIDAL PROPERTIES OF THE SERUM AGAINST GRAM-POSITIVE MICROBES IN PATIENTS SUFFERING FROM LEUKAEMIA, MALIGNANT LYMPHOMA, MYELOMA, AND MYELOFIBROSIS.
LIBANSKY J; JEZKOVA Z
Neoplasma; 1964; 11():71-87. PubMed ID: 14116776
[No Abstract] [Full Text] [Related]
15. Detection of human leukaemia associated antigens in leukaemic serum and normal embryos.
Harris R; Viza D; Todd R; Phillips J; Sugar R; Jennison RF; Marriott G; Gleeson MH
Nature; 1971 Oct; 233(5321):556-7. PubMed ID: 4329823
[No Abstract] [Full Text] [Related]
16. [Immunological behavior of patients with malignant blood diseases].
Luca N
Stud Cercet Med Interna; 1973; 14(5):429-46. PubMed ID: 4202394
[No Abstract] [Full Text] [Related]
17. HL-A antigens and hematologic malignancy.
Miller WV
Arch Intern Med; 1974 Mar; 133(3):397-9. PubMed ID: 4521322
[No Abstract] [Full Text] [Related]
18. [TUBERCULIN ANERGY AS A CRITERION OF BIOLOGICAL DELIMITATION OF MALIGNANT RETICULOPATHIES].
POPA M; POPA G; VEIZA L
Med Interna (Bucur); 1964 Jul; 16():811-8. PubMed ID: 14182762
[No Abstract] [Full Text] [Related]
19. Reticuloendothelial phagocytic function in patients with leukemia, lymphoma and multiple myeloma.
Groch GS; Perillie PE; Finch SC
Blood; 1965 Oct; 26(4):489-99. PubMed ID: 5212597
[No Abstract] [Full Text] [Related]
20. ACTIVE TUBERCULOSIS IN LEUKEMIA. MALIGNANT LYMPHOMA AND MYELOFIBROSIS.
MORROW LB; ANDERSON RE
Arch Pathol; 1965 May; 79():484-93. PubMed ID: 14289001
[No Abstract] [Full Text] [Related]
[Next] [New Search]
